Nika Beamon set out on a journey, and 26 doctors, 37 procedures and more than 17 years later, a rheumatologist finally ...

The FDA has approved Uplizna (inebilizumab-cdon) for the treatment of immunoglobulin G4-related disease in adult patients.

With autoimmune pancreatitis linked to a higher cancer risk, doctors must use comprehensive imaging to avoid unnecessary ...

As global stock markets experience significant fluctuations in April 2025 due to world trade conflicts, more investors are ...

More standardized research is needed to guide second-line agent selection in IgG4-RD. Rituximab offers a highly effective steroid-sparing option for the treatment of immunoglobulin G4-related disease ...

A key phase 3 readout in immune thrombocytopenia is due later this year, along with phase 2 results in asthma, IgG4-related disease, and warm autoimmune haemolytic anaemia, and phase 3 testing in ...

The FDA is currently reviewing the drug as a treatment for immunoglobulin G4-related disease (IgG4-RD), another rare disease that causes inflammation and fibrosis around the body, with a decision ...

They aimed to evaluate whether GLP-1 RAs protect against age-related ocular diseases (AMD, glaucoma, cataracts), while controlling for demographic and clinical confounders. Patients older than 60 ...